IJCTM/
Articles/
2508001037
  • Open Access
  • Mini-Review
The Triglyceride-Glucose Index: An Accessible Tool for Risk Stratification in Chronic Kidney Disease
  • Hulya Taskapan 1,   
  • Bharat Nathoo 2,   
  • Paul Tam 1, 3, *

Received: 10 Jun 2025 | Accepted: 27 Jun 2025 | Published: 09 Oct 2025

Abstract

Background: Chronic kidney disease (CKD) presents a significant global burden, requiring accessible risk assessment tools. Insulin resistance (IR), pivotal in cardiometabolic pathologies, contributes significantly to kidney injury and progression. The triglyceride-glucose (TyG) index offers a simple, cost-effective, insulin-independent surrogate for IR. This review synthesizes evidence on TyG’s utility, limitations, and future directions concerning kidney disease outcomes. Methods: A literature search was conducted in PubMed, Scopus, and Google Scholar for publications from December 2008 to May 2025. Systematic reviews, meta-analyses, and observational studies (cohort, cross-sectional) were included, examining TyG’s relationship with kidney disease (incident CKD, progression, DKD), T2DM as a DKD risk factor, and cardiometabolic outcomes in CKD populations. Results: Evidence from diverse cohorts has consistently shows elevated TyG index consistently associated with increased risk of incident T2DM, incident CKD, established CKD progression (including ESRD), and prevalent/incident diabetic kidney disease (DKD). Higher TyG also independently predicted increased cardiovascular events and mortality in CKD. Mechanistically, TyG reflects IR-driven pathways (endothelial dysfunction, oxidative stress, inflammation) linked to kidney damage. Existing challenges include the lack of standardized formula/thresholds and complex associations in diverse CKD subgroups. Conclusion: The TyG index is a promising marker for increased risk of developing and progressing CKD, including DKD. Although evidence demonstrates its association with adverse renal/cardiorenal outcomes, this needs to be clarified and standardized through robust clinical validation in diverse CKD populations, while adjusting for potential confounders to promote its application in CKD risk assessment.

References 

  • 1.
    Francis, A.; Harhay, M.N.; Ong, A.C.M.; et al. Chronic kidney disease and the global public health agenda: An international consensus. Nat. Rev. Nephrol. 2024, 20, 473–485.
  • 2.
    Di Pino, A.; DeFronzo, R.A. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocr. Rev. 2019, 40, 1447–1467.
  • 3.
    Artunc, F.; Schleicher, E.; Weigert, C.; et al. The impact of insulin resistance on the kidney and vasculature. Nat. Rev. Nephrol. 2016, 12, 721–737.
  • 4.
    Whaley-Connell, A.; Sowers, J.R. Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity. Cardiorenal Med. 2018, 8, 41–49.
  • 5.
    Li, M.; Chi, X.; Wang, Y.; et al. Trends in insulin resistance: Insights into mechanisms and therapeutic strategy. Signal Transduct. Target. Ther. 2022, 7, 216.
  • 6.
    Muniyappa, R.; Montagnani, M.; Koh, K.K.; et al. Cardiovascular Actions of Insulin. Endocr. Rev. 2007, 28, 463–491.
  • 7.
    de Boer, I.H.; Mehrotra, R. Insulin resistance in chronic kidney disease: A step closer to effective evaluation and treatment. Kidney Int. 2014, 86, 243–245.
  • 8.
    Petersen, M.C.; Shulman, G.I. Mechanisms of Insulin Action and Insulin Resistance. Physiol. Rev. 2018, 98, 2133–2223.
  • 9.
    Simental-Mendía, L.E.; Guerrero-Romero, F. The correct formula for the triglycerides and glucose index. Eur. J. Pediatr. 2020, 179, 1171.
  • 10.
    Wan, H.; Cao, H.; Ning, P. Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis. Sci. Rep. 2024, 14, 15499.
  • 11.
    Da Silva, A.; Caldas, A.P.S.; Rocha, D.M.U.P.; et al. Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk: A systematic review and meta-analysis of cohort studies. Prim. Care Diabetes 2020, 14, 584–593.
  • 12.
    Simental-Mendía, L.E.; Rodríguez-Morán, M.; Guerrero-Romero, F. The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metab. Syndr. Relat. Disord. 2008, 6, 299–304.
  • 13.
    Tuo, J.; Li, Z.; Xie, L. Association between triglyceride-glucose index and clinical outcomes among patients with chronic kidney disease: A meta-analysis. BMC Nephrol. 2025, 26, 61.
  • 14.
    Chen, N.; Ma, L.L.; Zhang, Y.; et al. Association of long-term triglyceride-glucose index patterns with the incidence of chronic kidney disease among non-diabetic population: Evidence from a functional community cohort. Cardiovasc. Diabetol. 2024, 23, 7.
  • 15.
    Wu, Y.; Liu, C.; Cao, J. Association between triglyceride-glucose index and its composite obesity indexes and cardio-renal disease: Analysis of the NHANES 2013–2018 cycle. Front. Endocrinol. 2025, 16, 1505808.
  • 16.
    Qin, Y.; Xuan, L.; Deng, Y.; et al. Triglyceride-glucose index and mortality risk in individuals with or without chronic kidney disease: Insights from a national survey of United States adults, 1999–2018. Nutr. Metab. Cardiovasc. Dis. 2024, 34, 1994–2001.
  • 17.
    Yu, C.; Shi, Y.; Wang, T.; et al. Triglyceride–glucose index change and chronic kidney disease progression in a Chinese hypertensive population. Front. Endocrinol. 2024, 15, 1342408.
  • 18.
    Kunutsor, S.K.; Seidu, S.; Kurl, S.; et al. Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: A prospective cohort study. GeroScience 2024, 46, 3035–3046.
  • 19.
    Huang, N.; Lu, B.; Zhu, Z.Z.; et al. The Association Between Triglyceride Glucose-Body Mass Index and Kidney Impairment in Patients with Type 2 Diabetes Mellitus. Diabetes Metab. Syndr. Obes. 2024, 17, 3447–3453.
  • 20.
    Chen, T.; Liu, Y.; Wu, S.; et al. Comparison of TyG and Newly TyG Related Indicators for Chronic Kidney Diseases Estimation in a Chinese Population. Diabetes Metab. Syndr. Obes. 2024, 17, 3063–3075.
  • 21.
    Ren, X.; Jiang, M.; Han, L.; et al. Association between triglyceride-glucose index and chronic kidney disease: A cohort study and meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2023, 33, 1121–1128.
  • 22.
    Shi, Y.; Hu, L.; Li, M.; et al. Association Between the Surrogate Markers of Insulin Resistance and Chronic Kidney Disease in Chinese Hypertensive Patients. Front. Med. 2022, 9, 831648.
  • 23.
    Okamura, T.; Hashimoto, Y.; Hamaguchi, M.; et al. Triglyceride-glucose index is a predictor of incident chronic kidney disease: A population-based longitudinal study. Clin. Exp. Nephrol. 2019, 23, 948–955.
  • 24.
    Lopez-Jaramillo, P.; Gomez-Arbelaez, D.; Martinez-Bello, D.; et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): A prospective cohort study. Lancet Healthy Longev. 2023, 4, e23–e33.
  • 25.
    Low, S.; Pek, S.; Moh, A.; et al. Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes—Mediation by pigment epithelium-derived factor. Diab. Vasc. Dis. Res. 2022, 19, 14791641221113784.
  • 26.
    Yoshida, D.; Ikeda, S.; Shinohara, K.; et al. Triglyceride-Glucose Index Associated with Future Renal Function Decline in the General Population. J. Gen. Intern. Med. 2024, 39, 3225–3233.
  • 27.
    Gao, Y.M.; Chen, W.J.; Deng, Z.L.; et al. Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease. Front. Endocrinol. 2023, 14, 1150980.
  • 28.
    Duan, S.; Zhou, M.; Lu, F.; et al. Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes. Endocrine 2023, 81, 77–89.
  • 29.
    Lv, L.; Zhou, Y.; Chen, X.; et al. Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus. Diabetes Metab. Syndr. Obes. 2021, 14, 3299–3306.
  • 30.
    Liu, L.; Xia, R.; Song, X.; et al. Association between the triglyceride–glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study. J. Diabetes Investig. 2021, 12, 557–565.
  • 31.
    Deng, S.; Peng, L. Triglyceride Glucose Index and the Risk of Diabetic Nephropathy in Patients with Type 2 Diabetes: A Meta-Analysis. Horm. Metab. Res. 2025, 57, 106–116.
  • 32.
    Chen, X.; Du, X.; Lu, F.; et al. The Association Between the Triglyceride-Glucose Index, Its Combination with the Body Roundness Index, and Chronic Kidney Disease in Patients with Type 2 Diabetes in Eastern China: A Preliminary Study. Nutrients 2025, 17, 492.
  • 33.
    Tatli, E. Hemoglobin glycation index and triglyceride-glucose index are related to diabetic nephropathy. Cirugía Cir. 2025, 93, 41–46.
  • 34.
    Ruiz-García, A.; Arranz-Martínez, E.; Serrano-Cumplido, A.; et al. From Metabolic Syndrome to Cardio-Kidney-Metabolic Syndrome in the SIMETAP Study: Prevalence Rates of Metabolic Syndrome and Its Independent Associations with Cardio-Renal-Metabolic Disorders Other than Its Defining Criteria. Biomedicines 2025, 13, 590.
  • 35.
    Yang, S.; Wang, Z. The triglyceride-glucose index is a promising predictor for the risk of cardiovascular disease in the diabetic population aged ≥60 years in the United States: A retrospective cohort study from NHANES (2007–2016). Front. Endocrinol. 2025, 16, 1475590.
  • 36.
    He, G.; Zhang, Z.; Wang, C.; et al. Association of the triglyceride–glucose index with all-cause and cause-specific mortality: A population-based cohort study of 3.5 million adults in China. Lancet Reg. Health–West. Pac. 2024, 49, 101135.
  • 37.
    Yu, Y.; Wang, J.; Ding, L.; et al. Sex differences in the nonlinear association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Diabetol. Metab. Syndr. 2023, 15, 136.
  • 38.
    Shang, J.; Yu, D.; Cai, Y.; et al. The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study. Medicine 2019, 98, e17995.
  • 39.
    Lee, E.Y.; Yang, H.K.; Lee, J.; et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016, 15, 155.
  • 40.
    Rong, L.; Hou, N.; Hu, J.; et al. The role of TyG index in predicting the incidence of diabetes in Chinese elderly men: A 20-year retrospective study. Front. Endocrinol. 2023, 14, 1191090.
  • 41.
    Chamroonkiadtikun, P.; Ananchaisarp, T.; Wanichanon, W. The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study. Prim. Care Diabetes 2020, 14, 161–167.
  • 42.
    Zhang, Q.; Xiao, S.; Jiao, X.; et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: Evidence from NHANES 2001–2018. Cardiovasc. Diabetol. 2023, 22, 279.
  • 43.
    Zhang, J.; Wang, R.; Liu, Q.; et al. Association of triglyceride-glucose index with incident hypertension among non-overweight healthy adults: A cohort study in China. Nutr. Metab. Cardiovasc. Dis. 2023, 33, 1057–1065.
  • 44.
    Guerrero-Romero, F.; Simental-Mendía, L.E.; González-Ortiz, M.; et al. The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. J. Clin. Endocrinol. Metab. 2010, 95, 3347–3351.
  • 45.
    Sánchez-García, A.; Rodríguez-Gutiérrez, R.; Saldívar-Rodríguez, D.; et al. Diagnostic accuracy of the triglyceride-glucose index for gestational diabetes screening: A practical approach. Gynecol. Endocrinol. 2020, 36, 1112–1115.
  • 46.
    Shen, R.; Lin, L.; Bin, Z.; et al. The U-shape relationship between insulin resistance-related indexes and chronic kidney disease: A retrospective cohort study from National Health and Nutrition Examination Survey 2007–2016. Diabetol. Metab. Syndr. 2024, 16, 168.
  • 47.
    Nayak, S.S.; Kuriyakose, D.; Polisetty, L.D.; et al. Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis. Cardiovasc. Diabetol. 2024, 23, 310.
  • 48.
    Wang, X.; Zheng, K.; Hu, X.; et al. The impact of sex-related disparities on the association between triglyceride-glucose index and renal function decline in patients with type 2 diabetes: Insights from the ACCORD trial. Diabetes Res. Clin. Pract. 2025, 224, 112163.
  • 49.
    Li, Z.; Xu, Z.; Xuan, C.; et al. Association between waist triglyceride index, body mass index, dietary inflammatory index, and triglyceride- glucose index with chronic kidney disease: The 1999–2018 cohort study from NHANES. Front. Endocrinol. 2024, 15, 1390725.
  • 50.
    Wei, S.; Wu, T.; You, Y.; et al. Correlation between the triglyceride-glucose index and chronic kidney disease among adults with metabolic-associated fatty liver disease: Fourteen-year follow-up. Front. Endocrinol. 2024, 15, 1400448.
  • 51.
    Chi, X.; Chen, S.; Huang, Z.; et al. Analysis of the correlation between the serum triglyceride glucose index and the risk of death in patients on maintenance hemodialysis: A retrospective cohort study. PeerJ 2025, 13, e18781.
  • 52.
    Nabipoorashrafi, S.A.; Adeli, A.; Seyedi, S.A.; et al. Comparison of insulin resistance indices in predicting albuminuria among patients with type 2 diabetes. Eur. J. Med. Res. 2023, 28, 166.
  • 53.
    Liu, L.; Sun, H.; Yi, L.; et al. Association between triglyceride-glucose index and cardiovascular disease in US adults with chronic kidney disease: A population-based study. BMC Cardiovasc. Disord. 2024, 24, 723.
Share this article:
Download PDF
DOI
10.53941/ijctm.2025.1000023
Issue
Volume 1, Issue 4
How to Cite
Taskapan, H.; Nathoo, B.; Tam, P. The Triglyceride-Glucose Index: An Accessible Tool for Risk Stratification in Chronic Kidney Disease. International Journal of Clinical and Translational Medicine 2025, 1 (4), 2. https://doi.org/10.53941/ijctm.2025.1000023.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2025 by the authors.